Lescol Tablet, Extended Release
NDC Package 66758-211-01
Package Information
Lescol (fluvastatin sodium) tablets is fluvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. This formulation utilizes a tablet, extended release delivery system. Marketed by Sandoz Inc, this product is identified by NDC 66758-211 and is authorized under FDA application NDA021192.
Identification & Billing
- RxCUI: 360507 - fluvastatin sodium 80 MG 24HR Extended Release Oral Tablet
- RxCUI: 360507 - 24 HR fluvastatin 80 MG Extended Release Oral Tablet
- RxCUI: 360507 - fluvastatin (as fluvastatin sodium) 80 MG 24 HR Extended Release Oral Tablet
- RxCUI: 360507 - fluvastatin 80 MG 24 HR Extended Release Oral Tablet
- RxCUI: 687048 - Lescol XL 80 MG 24HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 66758 - Sandoz Inc
- 66758-211 - Lescol
- 66758-211-01 - 100 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 66758-211 - Lescol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (66758-211). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66758-211-01 identifies a specific commercial package of 100 tablet, extended release in 1 bottle of Lescol XL, a human prescription drug labeled by Sandoz Inc. This tablet, extended release is formulated for oral use and contains fluvastatin sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sandoz Inc on October 06, 2000. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Fluvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.
How is this Sandoz Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66758021101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.